Calan is the brand name for the medication verapamil, which belongs to the class of calcium channel blockers. It is used primarily to treat hypertension and certain types of angina by relaxing blood vessels and improving blood flow. Clinically it helps reduce high blood pressure, relieve chest pain, and manage some arrhythmias. The active ingredient works by blocking l-type calcium channels in vascular smooth muscle and cardiac tissue. This blockade prevents calcium influx, leading to relaxation of arterial walls and decreased cardiac contractility. The resulting reduction in peripheral resistance lowers arterial pressure and the decreased contractility lessens the heart's oxygen demand. By improving coronary blood flow and reducing myocardial workload the medication alleviates ischemic chest discomfort. Overall its therapeutic effects stem from the selective inhibition of calcium channels that modulate vascular tone and cardiac function.

Calan is the brand name for the calcium channel blocker verapamil used primarily to treat hypertension and certain cardiac arrhythmias. Its pharmacological action involves binding to the l-type calcium channels in cardiac and vascular smooth muscle to reduce the movement of calcium ions across cell membranes. By inhibiting calcium influx the drug causes relaxation of coronary and peripheral blood vessels leading to lowered peripheral resistance and decreased blood pressure. The medication also slows conduction through the atrioventricular node which helps control heart rate in patients with certain arrhythmias. Clinically it is classified as an antihypertensive and antiarrhythmic agent that modulates vascular tone and myocardial contractility through its calcium antagonism. These key pharmacological features contribute to its use in managing high blood pressure and maintaining rhythm stability in selected cardiac conditions.

Calan may cause dizziness or lightheadedness especially when standing up quickly. It can lead to a slow heart rate known as bradycardia in some patients. Swelling of the ankles or feet is a possible sign of fluid retention. Headaches are commonly reported during the initial treatment period. Some individuals experience flushing or warmth in the face. Constipation and mild stomach discomfort are also observed side effects. Fatigue or a feeling of weakness may occur as the body adjusts to the medication.

Calan may cause dizziness in some individuals. It can also lead to a slow heart rate. Some people experience constipation. Swelling in the ankles is another possible effect. Headache and fatigue are commonly reported. These reactions do not affect everyone and can vary in severity.